How Fast Does GLP-1 Weight Loss Happen? The Real Timeline From the Trials
Short answer
Measurable within the first month, but slow at first and most of it later. In the STEP 1 trial, weight reduction on semaglutide was already evident at week 4.1 The catch is that the dose is stepped up every four weeks and the full 2.4 mg dose is not reached until week 16, so the early weeks are on a fraction of the eventual dose. The average loss at 68 weeks was about 15% of body weight.
Tirzepatide follows the same shape on a higher curve: the SURMOUNT-5 head-to-head found roughly 20% at 72 weeks versus roughly 14% for semaglutide.2
This is not medical advice. Tirzeptides is an independent comparison site, not a healthcare provider. Nothing here creates a doctor-patient relationship or replaces a conversation with a licensed clinician. GLP-1 medications are prescription drugs with real risks and contraindications. Talk to a qualified provider before starting, stopping or changing any treatment.
Why the first two months feel slow
Nobody starts on the full dose. Semaglutide is titrated from 0.25 mg through 0.5, 1.0 and 1.7 mg before reaching 2.4 mg at week 16; tirzepatide steps from 2.5 mg upward in a similar four-week rhythm. The starting doses exist to let the gut adapt, not to cause weight loss, and appetite suppression builds as the dose does.
So the honest expectation for month one is a few pounds — real, but not the headline number — with the rate picking up through months two to four as you approach the maintenance dose.
The trial timeline, roughly
These are group averages under trial conditions with lifestyle support, not a promise for any individual. Individual results spread widely on either side.
- Week 4: weight reduction already statistically evident on semaglutide.1
- Weeks 12–20: the steepest part of the curve for most people, as the maintenance dose is reached around week 16.
- Around week 20: the point at which most people have had their first gastrointestinal side effect if they are going to; new side effects plateau after this.1
- Week 68 (semaglutide): about 15% average loss in STEP 1, sustained to 104 weeks in the extension.
- Week 72 (tirzepatide vs semaglutide): about 20% versus about 14% in SURMOUNT-5.2
The curve flattens in the second year. That is a plateau, not the drug stopping working, and stopping the drug at that point typically reverses much of the loss.
Bodybuilding Health+
Clearest pricing ladder · scored 8.0/10
Save $480 a year on a 12-month plan
- Clear tiered pricing published for every bundle length
- Microdosing protocols available for people who want lower doses
- Wide catalogue: NAD+ and sermorelin from $129/mo, PT-141, glutathione, GHK-Cu
What changes the speed
- Dose reached. People who cannot tolerate the top dose and stay on a lower one lose less, more slowly. That is the most common reason real-world results lag the trials.
- Starting weight. Percentages are similar across starting weights; pounds are not. A 15% loss is 30 lb at 200 lb and 45 lb at 300 lb.
- Molecule. Tirzepatide is faster and larger on average, as above.
- Compounded vs approved. The figures here come from FDA-approved products. Compounded versions are not FDA-reviewed for potency, and a vial that delivers less drug than labelled will produce slower loss for reasons that have nothing to do with you.
The short version
Expect a little in month one, most of it in months two to six, and a plateau in year two. Semaglutide averages about 15% at 68 weeks; tirzepatide about 20% at 72 weeks. If you are three months in and have lost almost nothing, the first things to check are whether you have actually reached the maintenance dose and, if you are on a compounded product, what is in the vial. Provider plans and prices are on the price index; the two molecules are compared in tirzepatide vs semaglutide.
Sources
- Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss — Diabetes, Obesity and Metabolism (Wharton et al., 2022)
- Semaglutide — StatPearls — NIH National Library of Medicine
Our top three, compared
Ranked by the six published weights on how we rank. All three are paid partners.
Related questions
- Which GLP-1 is best for weight loss?
- Which GLP-1 is best for cardiovascular benefit?
- What does GLP-1 do in the body?
- How long do GLP-1 side effects last?
- Does compounded GLP-1 need to be refrigerated?
All GLP-1 questions answered → · GLP-1 price index → · Compare the 8 providers →